Rituximab for systemic sclerosis: arrest of pulmonary disease progression in five cases. Results of a lower dosage and shorter interval regimen.
F C Moazedi-Fuerst, S M Kielhauser, K Brickmann, J Hermann, A Lutfi, M Meilinger, H P Brezinschek, W B GraningerNo abstract text is available yet for this article.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.